Skip to content
Recall Observatory FDA recall evidence

Drug product

Ketorolac Tromethamine Injection, USP 60 mg/2 mL (30 mg/mL), packaged in 2 mL single dose vials, Rx Only, Nephron Pharmaceutical Corporation 4500 12th Street Extension West Columbia, SV 29172, NDC 0487-6232-01

D-1354-2022

August 10, 2022

Class II

Product summary

Firm
Nephron Sc Inc
Event
Event 90703
Status
Terminated
Classification
Class II
Quantity
5040 vials
Official record key
drug-enforcement:D-1354-2022

Official wording

Reason: cGMP Deviations: deviations leading to potential cross-contamination.

Code information: Lot#: 023011 Exp 8/31/2022

Distribution pattern: USA Nationwide

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    cGMP Deviations: deviations